<i>PALB2</i> analysis in the diagnostic process of breast cancer: An Italian monocentric experience
In conclusion, the germline analysis of <i>BRCA1, BRCA2</i> and <i>PALB2</i> should be included in breast cancer clinical practice as a not negligible number of <i>PALB2</i> carriers could be identified and referred to specific surveillance protocols.
Authors
- Ileana Carnevali (ORCID: https://orcid.org/0000-0002-0511-5427)
- Fausto Sessa (ORCID: https://orcid.org/0000-0002-6633-536X)
- Stefano La Rosa (ORCID: https://orcid.org/0000-0003-1941-2403)
- Francesca Rovera (ORCID: https://orcid.org/0000-0001-8172-3339)
- Corrado Chiappa (ORCID: https://orcid.org/0000-0002-6153-3156)
- Laura Libera (ORCID: https://orcid.org/0000-0003-2130-6669)
- Sofia Facchi (ORCID: https://orcid.org/0009-0003-1257-049X)
- Maria Grazia Tibiletti (ORCID: https://orcid.org/0000-0001-8471-1229)
Institutions
- University of Insubria (IT)
- Azienda Socio Sanitaria Territoriale Lariana (IT)
Publication Details
- Journal
- Tumori Journal
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1177/03008916241290738
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.55